Study

EORTC-1965-DECRESCENDO

De-Escalation of adjuvant ChemotheRapy in HER2-positive, EStrogen reCEptor-negative, Node-negative early breast cancer patients who achieved pathological complete response after neoadjuvant chemotherapy and Dual HER2 blOckade

Study documentation Back to result

Trial Status

All trial activities ended

Dates

Date of activation: 19-Jan-2022
Date Step1 close: 02-Oct-2023
Date Step2 close: 02-Oct-2023

Data management at EORTC

No

Design

Phase 2
Randomized open label

Targeted Sample size

EORTC Groups: 185 - All Groups: 1330

Protocol summary

http://clinicaltrials.gov/study/NCT04675827

NCT number

NCT04675827

EudraCT

2020-002918-41